Article ID Journal Published Year Pages File Type
4026006 Ophthalmology 2015 7 Pages PDF
Abstract
Most lesions with CNV became inactive with 3 injections of ranibizumab, but a small proportion remained active for more than 12 months. Injection frequency and lesion type were the main factors that predicted the time and number of injections required to render lesions inactive.
Related Topics
Health Sciences Medicine and Dentistry Ophthalmology
Authors
, , , , , , , , , , , , , , , ,